Syndax Pharmaceuticals, Inc. (SNDX) Presents at The 67th American Society of Hematology (ASH) Annual Meeting Transcript

ConversationMichael MetzgerCEO & Director Good morning, everyone. So thanks for joining today. We're excited to be here at ASH. Really exciting agenda today to walk through. And I'll start by making some opening remarks, and then we'll turn it over to our 4 esteemed thought leaders and PIs on our clinical trials. We're excited to have them here today, and I'll introduce them. So these are the doctors, who have been working on our trials and helping us advance our programs for quite some time and making a d ...